<?xml version="1.0" encoding="UTF-8"?><rss version="2.0">
<channel>
  <title>Nyheter om: SyntheticMR</title>
  <link>https://www.pressen.se/</link>
  <description>På Pressen.se kan du söka efter artiklar i svenska medier.</description>
    <pubDate>Fri, 06 Dec 2024 19:44:00 GMT</pubDate>
  <item>
    <title>SyntheticMR receives FDA 510(k) clearance for SyMRI 15</title>
    <pubDate>Fri, 06 Dec 2024 19:44:00 GMT</pubDate>
    <link>https://www.pressen.se/1105403587.html</link>
    <description>SyntheticMR, leader in quantitative imaging software, is pleased to announce that its SyMRI 15 solution has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) on diagnostic image replacement of conventional images..</description>
    <source>DI</source>
  </item>


  <item>
    <title>SyntheticMR Announces the Appointment of Francois Hebert as New President, North America</title>
    <pubDate>Wed, 04 Sep 2024 08:00:00 GMT</pubDate>
    <link>https://www.pressen.se/1069997043.html</link>
    <description>SyntheticMR is thrilled to announce the appointment of Francois Hebert as the new President of SyntheticMR, North America. With three decades of experience in healthcare and medical imaging, Frank brings extensive expertise from his recent senior leadership roles..</description>
    <source>DI</source>
  </item>
  <item>
    <title>SyntheticMR Receives Regulatory Approval for SyMRI in Taiwan</title>
    <pubDate>Mon, 19 Aug 2024 08:48:15 GMT</pubDate>
    <link>https://www.pressen.se/1064151837.html</link>
    <description>SyntheticMR announced today that its quantitative imaging software solution, SyMRI 12, has received regulatory approval from the Taiwan Food and Drug Administration (TFDA). This milestone enables the sale and distribution of SyMRI 12 in the Taiwanese market, paving the way for regional expansion..</description>
    <source>DI</source>
  </item>
  <item>
    <title>SyntheticMR and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR’s SyMRI NEURO Software at SimonMed Facilities.</title>
    <pubDate>Wed, 17 Apr 2024 08:15:00 GMT</pubDate>
    <link>https://www.pressen.se/1023181319.html</link>
    <description>SimonMed Imaging (&quot;SimonMed&quot;), one of the largest outpatient medical imaging providers and radiology practices in the United States, announces the continuation of its partnership with SyntheticMR for research as well as the upcoming expansion of synthetic availability from SyntheticMR’s SyMRI NEURO software at its facilities..</description>
    <source>DI</source>
  </item>
  <item>
    <title>SyntheticMR receives FDA 510(k) clearance for their next Generation Solution SyMRI 3D</title>
    <pubDate>Wed, 27 Mar 2024 10:01:35 GMT</pubDate>
    <link>https://www.pressen.se/1017996646.html</link>
    <description>SyntheticMR announced today that their next-generation imaging solution with isotropic resolution, SyMRI 3D, has received FDA 510(k) clearance for clinical use in the United States..</description>
    <source>DI</source>
  </item>
  <item>
    <title>Philips teams with SyntheticMR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients</title>
    <pubDate>Fri, 01 Mar 2024 08:00:00 GMT</pubDate>
    <link>https://www.pressen.se/1011389508.html</link>
    <description>Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and magnetic resonance imaging (MRI) software solutions company SyntheticMR (Linköping, Sweden) today announced the launch of Smart Quant Neuro 3D [1] – a major advance in objective decision support for diagnosis and therapy assessment of brain disorders like multiple sclerosis (MS), traumatic brain injury (TBI), and dementia. As healthcare providers strive to deliver high-quality care to patients, at #ECR2024 Philips is partnering with its customers to improve productivity and access to more sustainable healthcare..</description>
    <source>DI</source>
  </item>
  <item>
    <title>SyMRI 3D by SyntheticMR Set for Early 2024 Commercial Launch Post Obtaining CE-Marking</title>
    <pubDate>Mon, 18 Dec 2023 09:00:00 GMT</pubDate>
    <link>https://www.pressen.se/994769027.html</link>
    <description>SyntheticMR announced today that their next-generation imaging solution with isotropic 3D resolution, SyMRI 3D, has obtained approval in the EU and is now CE-Marked. With preparations in place, SyntheticMR eagerly anticipates the commercial launch of SyMRI 3D at the start of 2024..</description>
    <source>DI</source>
  </item>
  <item>
    <title>SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3D</title>
    <pubDate>Thu, 30 Nov 2023 08:43:36 GMT</pubDate>
    <link>https://www.pressen.se/989636972.html</link>
    <description>SyntheticMR announced today that they have expanded their partnership with Philips to include SyMRI 3D. .</description>
    <source>DI</source>
  </item>
  <item>
    <title>Linköpingsföretag anlitas i stort amerikanskt projekt</title>
    <pubDate>Thu, 03 Feb 2022 11:14:00 GMT</pubDate>
    <link>https://www.pressen.se/381410371.html</link>
    <description>Linköpingsföretaget SyntheticMR blir delaktigt i ett stort amerikanskt projekt som ska pågå i upp till tio år..</description>
    <source>NT</source>
  </item>
  <item>
    <title>Linköpingsföretag anlitas i stort amerikanskt projekt</title>
    <pubDate>Thu, 03 Feb 2022 09:21:00 GMT</pubDate>
    <link>https://www.pressen.se/381316216.html</link>
    <description>Linköpingsföretaget SyntheticMR blir delaktigt i ett stort amerikanskt projekt som ska pågå i upp till tio år..</description>
    <source>Corren</source>
  </item>
</channel>
</rss><!-- CR: cache is set: Sidan laddades på 0.099858999252319 s -->